Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 3/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | ACACA | Q13085 | 1/20 | 0.31 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27181873 | 1.00 | ACLY (0.32) | ACLYACACBACACAHSPD1BLM | |
| SCHEMBL6533666 | 1.00 | ACLY (0.32) | ACLYACACBACACAHSPD1BLM | |
| SCHEMBL706623 | 0.94 | ACLY (0.33) | ACLYACACBACACAHSPD1BLM | |
| SCHEMBL29786808 | 0.76 | PDE4A (0.41) | ACLY | |
| SCHEMBL17889062 | 0.70 | PDE4A (0.55) | PTPN1 | |
| SCHEMBL5168154 | 0.70 | PDE4A (0.55) | PTPN1 | |
| SCHEMBL436281 | 0.70 | PDE4A (0.55) | PTPN1 | |
| SCHEMBL28380507 | 0.70 | PDE4A (0.55) | PTPN1 | |
| SCHEMBL28496980 | 0.70 | PDE4A (0.55) | PTPN1 | |
| SCHEMBL28465166 | 0.68 | PDE4A (0.53) | PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115252449-B | Azelaic acid aqueous solution, preparation method thereof and cosmetic composition | 上海臻臣化妆品有限公司 | 2024-07-05 | — | — | CN | claimed |
| EP-4274545-A1 | STYLING CREAM CONTAINING NATURAL INGREDIENTS | Henkel AG & Co. KGaA (DE) | 2023-11-15 | — | — | EP | claimed |
| CN-115252449-A | Azelaic acid aqueous solution, preparation method thereof and cosmetic composition | 上海臻臣化妆品有限公司 | 2022-11-01 | — | — | CN | claimed |
| US-10589133-B2 | Cosmetic preparation and use thereof | SCHWAN-STABILO COSMETICS GMBH & CO. KG (DE) | 2020-03-17 | — | — | US | claimed |
| EP-2531171-B1 | COSMETIC FORMULATION AND USE THEREOF | SCHWAN STABILO COSMETICS GMBH (DE) | 2016-07-06 | — | — | EP | claimed |
| US-20120288462-A1 | COSMETIC PREPARATION AND USE THEREOF | SCHWAN-STABILO COSMETICS GMBH & CO. KG (DE) | 2012-11-15 | — | — | US | claimed |
| CN-115252449-B | Azelaic acid aqueous solution, preparation method thereof and cosmetic composition | 上海臻臣化妆品有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-113710329-B | Personal care compositions | 高露洁-棕榄公司 | 2024-04-05 | — | — | CN | disclosed |
| EP-4274545-A1 | STYLING CREAM CONTAINING NATURAL INGREDIENTS | Henkel AG & Co. KGaA (DE) | 2023-11-15 | — | — | EP | disclosed |
| CN-115252449-A | Azelaic acid aqueous solution, preparation method thereof and cosmetic composition | 上海臻臣化妆品有限公司 | 2022-11-01 | — | — | CN | disclosed |
| US-20220023189-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2022-01-27 | — | — | US | disclosed |
| US-20220000755-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2022-01-06 | — | — | US | disclosed |
| EP-3873412-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2021-09-08 | — | — | EP | disclosed |
| US-10589133-B2 | Cosmetic preparation and use thereof | SCHWAN-STABILO COSMETICS GMBH & CO. KG (DE) | 2020-03-17 | — | — | US | disclosed |
| WO-2019136351-A1 | PERSONAL CARE COMPOSITIONS | ALTUS LABS, LLC (US) | 2019-07-11 | — | — | WO | disclosed |
| US-20140080924-A1 | SELF-EMULSIFYING AND STABILIZING GEL FOR STABILIZING COSMETIC COMPOSITIONS | RIGG RICHARD T (US) | 2014-03-20 | — | — | US | disclosed |
| US-20120288462-A1 | COSMETIC PREPARATION AND USE THEREOF | SCHWAN-STABILO COSMETICS GMBH & CO. KG (DE) | 2012-11-15 | — | — | US | disclosed |
| US-20100111884-A1 | UV ABSORBER FORMULATIONS | CIBA CORPORATION (US) | 2010-05-06 | — | — | US | disclosed |
| EP-2099530-A1 | UV ABSORBER FORMULATIONS | Ciba Holding Inc. (CH) | 2009-09-16 | — | — | EP | disclosed |
| WO-2008080892-A1 | UV ABSORBER FORMULATIONS | CIBA HOLDING INC. (CH) | 2008-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100111884-A1 | UV ABSORBER FORMULATIONS | C1R, C1S, C9 | ACLY 3581/4885ACACB 2940/4885ACACA 2624/4885 |
| US-20140080924-A1 | SELF-EMULSIFYING AND STABILIZING GEL FOR STABILIZING COSMETIC COMPOSITIONS | SGMS2, LAGE3, POLG | ACLY 1906/4885ACACB 876/4885ACACA 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.